Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Long-term Somatropin Treatment in Adults (NordiWIN)
This study is enrolling participants by invitation only.
Study NCT01543880   Information provided by Novo Nordisk

First Received on February 28, 2012.   Last Updated on June 26, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Growth Hormone Disorder
Adult Growth Hormone Deficiency
Additional conditions recognized in this trial
Dwarfism, Pituitary
Endocrine System Diseases
More general conditions related to this trial
Bone Diseases
Bone Diseases, Developmental
Bone Diseases, Endocrine
Brain Diseases
Central Nervous System Diseases
Dwarfism
Hypopituitarism
Hypothalamic Diseases
Musculoskeletal Diseases
Nervous System Diseases
Pituitary Diseases
Interventions listed in this trial
somatropin
Sponsors listed in this trial
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services